Lori Christman

535 total citations
11 papers, 394 citations indexed

About

Lori Christman is a scholar working on Pathology and Forensic Medicine, Oncology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Lori Christman has authored 11 papers receiving a total of 394 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 4 papers in Oncology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Lori Christman's work include Radiopharmaceutical Chemistry and Applications (3 papers), Breast Cancer Treatment Studies (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Lori Christman is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (3 papers), Breast Cancer Treatment Studies (3 papers) and Lymphoma Diagnosis and Treatment (3 papers). Lori Christman collaborates with scholars based in United States, Israel and India. Lori Christman's co-authors include Dennis W. King, Anne M. Wallace, Schlomo Schneebaum, Mark B. Faries, Nathan C. Hall, David R. Vera, Jonathan S. Zager, Julian Kim, Stanley P. L. Leong and Christopher A. Puleo and has published in prestigious journals such as Journal of Clinical Oncology, Journal of General Internal Medicine and Annals of Surgical Oncology.

In The Last Decade

Lori Christman

10 papers receiving 382 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lori Christman United States 7 172 142 96 82 79 11 394
Heike Scheithauer Germany 13 133 0.8× 69 0.5× 130 1.4× 34 0.4× 101 1.3× 15 377
Hongjiang Yan China 14 257 1.5× 232 1.6× 118 1.2× 60 0.7× 42 0.5× 33 543
Ronny Kalash United States 13 122 0.7× 146 1.0× 67 0.7× 33 0.4× 139 1.8× 36 506
Samuel Leung France 7 125 0.7× 142 1.0× 93 1.0× 60 0.7× 68 0.9× 7 377
Gregor J. Förster Germany 11 83 0.5× 60 0.4× 44 0.5× 78 1.0× 270 3.4× 18 482
Rafke Schoffelen Netherlands 10 209 1.2× 136 1.0× 30 0.3× 76 0.9× 230 2.9× 12 430
Jenny Ling‐Yu Chen Taiwan 14 133 0.8× 86 0.6× 51 0.5× 18 0.2× 64 0.8× 37 461
Gregory M. Richards United States 13 102 0.6× 162 1.1× 75 0.8× 57 0.7× 174 2.2× 15 632
Ding‐Jen Lee United States 12 181 1.1× 188 1.3× 58 0.6× 44 0.5× 37 0.5× 22 459
Su Mei Cao China 6 281 1.6× 140 1.0× 137 1.4× 45 0.5× 26 0.3× 19 586

Countries citing papers authored by Lori Christman

Since Specialization
Citations

This map shows the geographic impact of Lori Christman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lori Christman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lori Christman more than expected).

Fields of papers citing papers by Lori Christman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lori Christman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lori Christman. The network helps show where Lori Christman may publish in the future.

Co-authorship network of co-authors of Lori Christman

This figure shows the co-authorship network connecting the top 25 collaborators of Lori Christman. A scholar is included among the top collaborators of Lori Christman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lori Christman. Lori Christman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Makale, Milan, Lori Christman, J. Kaci Fairchild, et al.. (2023). Personalized repetitive transcranial magnetic stimulation (prtms®) for post-traumatic stress disorder (ptsd) in military combat veterans. Heliyon. 9(8). e18943–e18943. 9 indexed citations
2.
Davis, Terry C., et al.. (2022). Evaluating Health Literacy in Virtual Environments: Validation of the REALM and REALM-Teen for Virtual Use. Journal of General Internal Medicine. 37(11). 2834–2839.
3.
Kardan, Arash, David Ralph, Michael Rosol, et al.. (2019). A Phase I/Phase II Study of Intravenously (IV) Administered Tc 99m Tilmanocept (TCT) to Determine Safety, Tolerability, Optimal Clinical Dose Selection, and Imaging Timepoint in Patients Clinically Diagnosed with Rheumatoid Arthritis (RA). 60. 89–89. 1 indexed citations
4.
5.
Christman, Lori, et al.. (2016). Prospective, Double-Blind, Randomized Study to Evaluate Single-Injection Adductor Canal Nerve Block Versus Femoral Nerve Block. Regional Anesthesia & Pain Medicine. 42(1). 10–16. 37 indexed citations
6.
Agrawal, Amit, Francisco Civantos, Kevin T. Brumund, et al.. (2015). [99mTc]Tilmanocept Accurately Detects Sentinel Lymph Nodes and Predicts Node Pathology Status in Patients with Oral Squamous Cell Carcinoma of the Head and Neck: Results of a Phase III Multi-institutional Trial. Annals of Surgical Oncology. 22(11). 3708–3715. 88 indexed citations
7.
Wallace, Anne M., Linda K. Han, Stephen P. Povoski, et al.. (2013). Comparative Evaluation of [99mTc]Tilmanocept for Sentinel Lymph Node Mapping in Breast Cancer Patients: Results of Two Phase 3 Trials. Annals of Surgical Oncology. 20(8). 2590–2599. 87 indexed citations
8.
Tokin, Christopher, Frederick O. Cope, B. Potter, et al.. (2012). The efficacy of Tilmanocept in sentinel lymph mode mapping and identification in breast cancer patients: a comparative review and meta-analysis of the 99mTc-labeled nanocolloid human serum albumin standard of care. Clinical & Experimental Metastasis. 29(7). 681–686. 41 indexed citations
9.
Sondak, Vernon K., Dennis W. King, Jonathan S. Zager, et al.. (2012). Combined Analysis of Phase III Trials Evaluating [99mTc]Tilmanocept and Vital Blue Dye for Identification of Sentinel Lymph Nodes in Clinically Node-Negative Cutaneous Melanoma. Annals of Surgical Oncology. 20(2). 680–688. 106 indexed citations
10.
Li, Lily, et al.. (2012). A multiplex serum protein assay for determining the probability of colorectal cancer.. PubMed. 2(5). 598–605. 21 indexed citations
11.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Heike Scheithauer Breakdown of academic impact, for papers by Hongjiang Yan Breakdown of academic impact, for papers by Ronny Kalash Breakdown of academic impact, for papers by Samuel Leung Breakdown of academic impact, for papers by Gregor J. Förster Breakdown of academic impact, for papers by Rafke Schoffelen Breakdown of academic impact, for papers by Jenny Ling‐Yu Chen Breakdown of academic impact, for papers by Gregory M. Richards Breakdown of academic impact, for papers by Ding‐Jen Lee Breakdown of academic impact, for papers by Su Mei Cao
Rankless by CCL
2026